摘要
目的探究肿瘤标志物CA724、CEA、CA242、CA199在胃癌检验中的临床应用价值。方法选取本院2015年2月到2016年2月收治胃癌患者450例作为胃癌组,选取同期患其他胃部疾病患者450例作为对照组。对900例患者进行肿瘤标志物CA724、CEA、CA242、CA199的联合检验,并与病理结果分析其检验结果。结果胃癌组联合检测结果高于对照组,对比显示具有统计学意义(P<0.05);胃癌组Ⅰ期、Ⅱ期、Ⅲ期肿瘤标志物联合检验阳性率优于单项检验阳性率,对比显示存在统计学意义(P<0.05)。结论肿瘤标志物CA724、CEA、CA242、CA199可有效帮助胃癌患者及早确诊病情。
Objective To analyze the clinical application of combined examination methods of CA724,CEA,CA242 and CA199 in patients with gastric carcinoma.Methods 450 patients with stomach disease treated from February 2015 to February 2016 in our hospital were selected.The control group was selected as the control group of 450 patients with other gastric diseases.The tumor markers CA724,CEA,CA242 and CA199 were detected and analyzed.Results The detection rate of combined examination methods was higher than that of control group （P〈0.05）.The positive rates of tumor markers in gastric cancer group I,II and III were better than the single test positive rate,and the comparison showed statistical significance （P〈0.05）.Conclusion The combined examination methods of CA724,CEA,CA242 and CA199 is good to confirm the gastric carcinoma patient＇s conditions as soon as possible.
出处
《辽宁医学杂志》
2017年第2期1-2,共2页
Medical Journal of Liaoning
关键词
胃癌
肿瘤标志物
联合检验
Gastric carcinoma
Tumor marker
Combined examination methods
